Wells Fargo’s New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a NFH.WS Stock Holding History

Wells Fargo’s Portfolio NFH.WS Stock Details NFH.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,000	Closed	-$5K	–	7864
2021 Q2	$5K	Hold	2,000	–	–	﹤0.01%	6374
2021 Q1	$4K	Hold	2,000	–	–	﹤0.01%	6562
2020 Q4	$4K	Buy	+2,000	New	+$3.97K	﹤0.01%	6211

Other funds holding NFH.WS

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

MAM

Myriad Asset Management North Point, Hong Kong $722M AUM 11.94% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $8.89B AUM 39.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

EPM

Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return

Wells Fargo's NFH.WS Position: Q3 2021 in Review

Wells Fargo sold out of New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) in Q3 2021, closing a stake of 2,000 shares — an estimated $5K sold.

Wells Fargo first reported a position in NFH.WS in Q4 2020 and held it in 3 quarters. The position peaked at $5K in Q2 2021. 11 funds tracked by Wall St. Rank hold NFH.WS as of Q3 2021.

Wells Fargo reported no remaining New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position as of Q3 2021 after selling out during the quarter.
Wells Fargo sold 2,000 New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a shares in Q3 2021, an estimated $5K.
Wells Fargo first reported a position in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a in Q4 2020 and held it in 3 quarters.
Wells Fargo's New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position peaked at $5K in Q2 2021.
11 funds tracked by Wall St. Rank held New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a as of Q3 2021.

Based on Wells Fargo's 13F filing for Q3 2021, filed 15 Nov 2021.